Evidence map›Paper›PMID 35139367›Full record

ArticleCell reports2022

Follicular T cells optimize the germinal center response to SARS-CoV-2 protein vaccination in mice.

Cecilia B Cavazzoni, Benjamin L Hanson, Manuel A Podestà, Elsa D Bechu, Rachel L Clement, Hengcheng Zhang, Joe Daccache, Tamara Reyes-Robles, Erik C Hett, Kalpit A Vora and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Targeting T follicular helper cells for lifelong health.Nature reviews. Drug discovery · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Progressively differentiated TNature immunology · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. T cell help shapes B cell tolerance.Science immunology · 2024
    Article
  17. Targeted checkpoint control of B cells undergoing positive selection in germinal centers by follicular regulatory T cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Cecilia B CavazzoniTransplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Benjamin L HansonTransplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Manuel A PodestàTransplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Renal Division, Department of Health Sciences, Università degli Studi di Milano, Milano, Italy.
Elsa D BechuTransplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Rachel L ClementTransplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Hengcheng ZhangTransplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Joe DaccacheTransplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Tamara Reyes-RoblesMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA 02141, USA.
Erik C HettMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA 02141, USA.
Kalpit A VoraMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA 02141, USA; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc., West Point, PA, USA.
Olugbeminiyi O FadeyiMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA 02141, USA.
Rob C OslundMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA 02141, USA.
Daria J HazudaMerck Exploratory Science Center, Merck & Co., Inc., Cambridge, MA 02141, USA; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc., West Point, PA, USA.
Peter T SageTransplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: psage@bwh.harvard.edu.
Brigham and Women's Hospital · USMerck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

Humoral Immunoregulation of Allergic Disease by Follicular T Cell SubsetsR01AI153124 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Peter The Sage · 2021 to 2026
$3.2M
Control of Humoral and Cellular Immunity to Viral Infections of the Lung by Follicular CD8 T CellsR01AI158413 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI SAGE, PETER THE · 2021 to 2025
$2.5M
Integrated Analysis of SARS-CoV-2 Vaccine Responses During AgingR21AI158175 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI SAGE, PETER THE · 2021 to 2022
$467k
NIAID NIH HHS R01 AI153124NIAID NIH HHS R01 AI158413NIAID NIH HHS R21 AI158175
6 · The paper itself

Abstract

Follicular helper T (Tfh) cells promote, whereas follicular regulatory T (Tfr) cells restrain, germinal center (GC) reactions. However, the precise roles of these cells in the complex GC reaction remain poorly understood. Here, we perturb Tfh or Tfr cells after SARS-CoV-2 spike protein vaccination in mice. We find that Tfh cells promote the frequency and somatic hypermutation (SHM) of Spike-specific GC B cells and regulate clonal diversity. Tfr cells similarly control SHM and clonal diversity in the GC but do so by limiting clonal competition. In addition, deletion of Tfh or Tfr cells during primary vaccination results in changes in SHM after vaccine boosting. Aged mice, which have altered Tfh and Tfr cells, have lower GC responses, presenting a bimodal distribution of SHM. Together, these data demonstrate that GC responses to SARS-CoV-2 spike protein vaccines require a fine balance of positive and negative follicular T cell help to optimize humoral immunity.

Indexed as

AgingAnimalsAntibodies, ViralB-LymphocytesCOVID-19Germinal CenterImmunity, HumoralMiceMice, Inbred C57BLSARS-CoV-2Spike Glycoprotein, CoronavirusT-Lymphocytes, Helper-InducerT-Lymphocytes, RegulatoryVaccinationVaccines, SubunitAntibodies, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Vaccines, Subunitaffinity maturationaginggerminal centerSARS-CoV-2somatic hypermutationTfhTfrvaccines

Identifiers

PMID35139367
PMCPMC8806144
OpenAlexW4210298817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.